Most health and wellness brands know, at least loosely, that FDA adverse event reporting is something they have to deal with. What a lot of them get wrong is the scope of it, which categories it applies to, when the clock starts, and crucially, which channels count as official notice.
This post covers the core obligations, the most commonly misunderstood parts, and what brands actually need to have in place to stay compliant.
What Is an Adverse Event?
An adverse event, in the context of FDA regulation, is any health-related incident associated with the use of a product, a supplement, cosmetic, OTC drug, or medical device. It doesn’t require proof of causation. A consumer reporting that they experienced a severe rash after using your moisturiser is a potential adverse event, regardless of whether the product actually caused it.
A serious adverse event is a more specific designation. Under both DSHEA (for dietary supplements) and MOCRA (for cosmetics), serious means any reported outcome involving:
- Hospitalisation
- Life-threatening illness or injury
- Persistent or significant disability or incapacity
- Congenital anomaly or birth defect
- Death
- A condition requiring medical or surgical intervention to prevent one of the above
If a consumer reports any of those outcomes in connection with your product, you have a legal obligation to report it to the FDA.
Which Brands Have FDA Adverse Event Reporting Obligations?
This is where a lot of brands assume they’re outside the scope and they’re not. FDA adverse event reporting requirements apply to:
Dietary Supplement Brands
Under the Dietary Supplement and Nonprescription Drug Consumer Protection Act, dietary supplement manufacturers and distributors must submit serious adverse event reports to the FDA within 15 business days of becoming aware of the event. There is also a mandatory one-year record-keeping requirement.
Cosmetics Brands
Since December 2023, the Modernization of Cosmetics Regulation Act (MOCRA) requires responsible persons, manufacturers, packers, distributors, to report serious adverse events to the FDA. The report must be submitted within 15 business days of receiving the report, with a 1-year follow-up window for any new or material information.
OTC Drug Brands
OTC drug manufacturers have had mandatory adverse event reporting obligations under 21 CFR Part 310 for considerably longer. The 15-day reporting requirement for serious and unexpected adverse events applies here too.
VMS (vitamins, minerals, supplements) brands, nutraceuticals, herbal supplement companies and personal care brands with products making OTC drug claims all fall somewhere in this landscape. If you’re not sure which category applies to your products, that’s a conversation worth having with your regulatory counsel.
When Does the Clock Start?
This is the part most brands underestimate: the reporting window opens the moment the brand becomes aware of a serious adverse event, not when a formal complaint is filed, not when a customer service email is received, not when someone officially notifies you through an established channel.
Awareness is the trigger.
And awareness includes social media.
A comment on your Instagram post describing a serious reaction. A tagged TikTok from a consumer saying they ended up in hospital. A reply on Facebook mentioning they needed medical treatment. All of those constitute the brand becoming aware, and the 15-day clock is running from the moment that content goes live.
The FDA has not published definitive guidance specifically addressing social media awareness, but the statutory language is clear: awareness triggers the obligation. Brands that assume social media is a grey area are taking a regulatory risk that isn’t supported by a careful reading of the law.
Why Social Media Is the Hardest Part of Compliance to Manage
Consumers don’t report adverse events using regulatory language. Nobody posts “I wish to notify the responsible person of a serious adverse event per 21 CFR requirements.” They write:
- “ended up in A&E after using this”
- “had a terrible reaction, my face was completely swollen”
- “doctor told me to stop immediately”
- “this put me in hospital for two days”
Keyword monitoring for “adverse event” or “serious reaction” will catch almost none of this. Manual moderation teams reviewing thousands of comments can miss it, especially on high-volume accounts or during campaign periods when comment activity spikes.
The challenge isn’t that brands don’t care, most do. The challenge is that the volume and language of social media doesn’t map neatly onto the compliance infrastructure most brands have built, which was designed around formal complaint submissions, not comments sections.
What a Compliant Adverse Event Monitoring Process Looks Like
There’s no single prescribed method for social media monitoring, the FDA specifies the obligation, not the method. But a defensible process should cover:
Continuous Monitoring
Not weekly reports. Not daily batches. Continuous. A serious adverse event posted at 11pm on a Friday needs to be captured before the end of the next business day if you’re going to stay within the 15-day window. Any monitoring approach that introduces significant delays creates compliance exposure.
Natural Language Detection
The system, whether human or automated, needs to understand how consumers actually describe adverse reactions, not just look for regulatory terms. That means detecting intent and severity from conversational language across multiple languages and registers.
Severity Triage
Not every complaint is a reportable adverse event. A system that flags everything creates noise that buries real events. Triage by severity, separating minor product complaints from potential serious adverse events, is essential for a team to function at scale.
Reporter Outreach
FDA reports require specific information: the product, the reporter’s contact details, the nature of the event, the outcome. When a potential serious adverse event is detected, someone needs to reach out to the consumer to gather that information. This step can be automated, but it has to happen, and quickly.
Audit Trail
If the FDA ever questions your monitoring process, you need documentation. Every detection, every outreach attempt, every review decision should be logged with timestamps. A process without an audit trail is a liability, you may have done everything right and still not be able to prove it.
The Business Case Beyond Compliance
Regulatory compliance is the floor, not the ceiling. Brands that build robust adverse event monitoring infrastructure also get something else: the ability to run active, open social media channels without the compliance anxiety that leads a lot of health and wellness brands to throttle engagement.
Turning off comments, restricting DMs, limiting UGC, these are all compliance-driven decisions that cost brands reach, community, and revenue. A monitoring system that gives your team confidence means your marketing function doesn’t have to be constrained by what your compliance function is afraid of.
How Moderaigent Handles This
Moderaigent is built specifically for health and wellness brands managing adverse event reporting obligations on social media. It monitors connected social channels continuously, detects potential adverse events in natural language, triages by severity, automates consumer outreach, and logs everything.
The result is a compliant process that runs 24/7 without manual oversight, and without your team having to scroll through thousands of comments hoping nothing serious slipped through.
If you’re a supplement, cosmetics, VMS, or OTC brand with active social channels, Moderaigent is worth a look. Start a free trial or book a demo to see it in action.
